Advertisement
Advertisement
BMRA
BIOMERICA INC
1.63
USDSponsored
+0.02
+1.24%
Aug 10, 15:59 UTC -4
Closed
After-Market
1.66
+0.03
+1.53%
BMRA Earnings Reports
Positive Surprise Ratio
BMRA beat 10 of 18 last estimates.
56%
Next Report
Date of Next Report
Aug 27, 2026
Estimate for Q4 26 (Revenue/ EPS)
--
/--
Implied change from Q3 26 (Revenue/ EPS)
--
/--
Implied change from Q4 25 (Revenue/ EPS)
--
/--
BIOMERICA INC earnings per share and revenue
On Apr 13, 2026, BMRA reported earnings of -0.44 USD per share (EPS) for Q3 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached 990.00 thousand, compared to an expected --, with a --% difference. The market reacted with a +0.96% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Oruka Therapeutics, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.52
Actual
-$0.55
Surprise
-4.62%
Definium Therapeutics, Inc. Common Shares
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.55
Actual
-$1.44
Surprise
-158.25%
Harrow, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.18
Actual
-$0.34
Surprise
-85.19%
Ardelyx, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.05
Actual
-$0.07
Surprise
-18.85%
Ironwood Pharmaceuticals, Inc. - Class A
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.36
Actual
$0.31
Surprise
-14.62%
Relmada Therapeutics, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.20
Actual
-$0.11
Surprise
+45.95%
OmniAb, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.12
Actual
-$0.05
Surprise
+59.15%
Nature's Sunshine Products Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.27
Actual
$0.21
Surprise
-23.75%
Tonix Pharmaceuticals Holding Corp.
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$2.75
Actual
-$2.44
Surprise
+11.29%
Fractyl Health, Inc. Common Stock
Report Date
Aug 10, 2026 For Q2 26
Estimate
-$0.13
Actual
-$0.12
Surprise
+12.85%
FAQ
What were BIOMERICA INC's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, BIOMERICA INC reported EPS of -$0.44, missing estimates by --, and revenue of $990.00K, -- -- expectations.
How did the market react to BIOMERICA INC's Q3 2026 earnings?
The stock price moved up 0.96%, changed from $2.08 before the earnings release to $2.10 the day after.
When is BIOMERICA INC expected to report next?
The next earning report is scheduled for Aug 27, 2026.
What are the forecasts for BIOMERICA INC's next earnings report?
Based on --
analysts, BIOMERICA INC is expected to report EPS of -- and revenue of -- for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement